These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34284539)

  • 1. Are central nervous system drugs displaying anti-inflammatory activity suitable for early treatment of COVID-19?
    Grieb P; Rejdak K
    Folia Neuropathol; 2021; 59(2):113-120. PubMed ID: 34284539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvoxamine and Amantadine: Central Nervous System Acting Drugs Repositioned for COVID-19 as Early Intervention.
    Rejdak K; Grieb P
    Curr Neuropharmacol; 2022; 20(4):777-781. PubMed ID: 34325642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence.
    Facente SN; Reiersen AM; Lenze EJ; Boulware DR; Klausner JD
    Drugs; 2021 Dec; 81(18):2081-2089. PubMed ID: 34851510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants-A Scoping Review.
    Bonnet U; Juckel G
    J Clin Psychopharmacol; 2022 May-Jun 01; 42(3):284-292. PubMed ID: 35420565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use.
    Foletto VS; da Rosa TF; Serafin MB; Hörner R
    Eur J Clin Pharmacol; 2022 Oct; 78(10):1601-1611. PubMed ID: 35943535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluvoxamine for COVID-19?
    Med Lett Drugs Ther; 2021 May; 63(1623):69-70. PubMed ID: 33976099
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs, Metabolites, and Lung Accumulating Small Lysosomotropic Molecules: Multiple Targeting Impedes SARS-CoV-2 Infection and Progress to COVID-19.
    Blaess M; Kaiser L; Sommerfeld O; Csuk R; Deigner HP
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvoxamine for symptomatic outpatients with COVID-19.
    Wu PE; Austin E; Leong D
    CMAJ; 2022 Feb; 194(7):E258. PubMed ID: 35045990
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review.
    Cantini F; Goletti D; Petrone L; Najafi Fard S; Niccoli L; Foti R
    Drugs; 2020 Dec; 80(18):1929-1946. PubMed ID: 33068263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment.
    Smieszek SP; Przychodzen BP; Polymeropoulos MH
    Int J Antimicrob Agents; 2020 Jun; 55(6):106004. PubMed ID: 32361028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amantadine Inhibits SARS-CoV-2 In Vitro.
    Fink K; Nitsche A; Neumann M; Grossegesse M; Eisele KH; Danysz W
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33804989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in management of COVID-19: A review.
    Mouffak S; Shubbar Q; Saleh E; El-Awady R
    Biomed Pharmacother; 2021 Nov; 143():112107. PubMed ID: 34488083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetic Aspects of COVID-19 Management and Post-COVID-19 Depression Treatment with Fluvoxamine.
    Dobrodeeva V; Abdyrahmanova A; Astafeva D; Smirnova D; Cumming P; De Sousa A; Davydkin I; Yashikhina A; Shnayder N; Nasyrova R
    Psychiatr Danub; 2022 Sep; 34(Suppl 8):25-30. PubMed ID: 36170697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
    Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
    Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
    García IG; Rodriguez-Rubio M; Mariblanca AR; de Soto LM; García LD; Villatoro JM; Parada JQ; Meseguer ES; Rosales MJ; González J; Arribas JR; Carcas AJ; de la Oliva P; Borobia AM
    Trials; 2020 Jun; 21(1):466. PubMed ID: 32493475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial.
    Reis G; Dos Santos Moreira-Silva EA; Silva DCM; Thabane L; Milagres AC; Ferreira TS; Dos Santos CVQ; de Souza Campos VH; Nogueira AMR; de Almeida APFG; Callegari ED; de Figueiredo Neto AD; Savassi LCM; Simplicio MIC; Ribeiro LB; Oliveira R; Harari O; Forrest JI; Ruton H; Sprague S; McKay P; Glushchenko AV; Rayner CR; Lenze EJ; Reiersen AM; Guyatt GH; Mills EJ;
    Lancet Glob Health; 2022 Jan; 10(1):e42-e51. PubMed ID: 34717820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential for the Repurposing of Adamantane Antivirals for COVID-19.
    Butterworth RF
    Drugs R D; 2021 Sep; 21(3):267-272. PubMed ID: 34152583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents.
    Perico N; Cortinovis M; Suter F; Remuzzi G
    Lancet Infect Dis; 2023 Jan; 23(1):e22-e33. PubMed ID: 36030796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of antidepressants on the severity of COVID-19 in hospitalized patients: A systematic review and meta-analysis.
    Nakhaee H; Zangiabadian M; Bayati R; Rahmanian M; Ghaffari Jolfayi A; Rakhshanderou S
    PLoS One; 2022; 17(10):e0267423. PubMed ID: 36201406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Role of the Antidepressants Fluoxetine and Fluvoxamine in the Treatment of COVID-19.
    Mahdi M; Hermán L; Réthelyi JM; Bálint BL
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.